These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6644694)

  • 1. The tight-skin mouse: is it a model for scleroderma?
    Russell ML
    J Rheumatol; 1983 Oct; 10(5):679-81. PubMed ID: 6644694
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of endothelial cell apoptosis in the dermis of tight skin 1 and tight skin 2 mice.
    Sgonc R; Dietrich H; Sieberer C; Wick G; Christner PJ; Jiménez SA
    Arthritis Rheum; 1999 Mar; 42(3):581-4. PubMed ID: 10088787
    [No Abstract]   [Full Text] [Related]  

  • 3. The tight-skin mouse: physical and biochemical properties of the skin.
    Osborn TG; Bauer NE; Ross SC; Moore TL; Zuckner J
    J Rheumatol; 1983 Oct; 10(5):793-6. PubMed ID: 6644702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent advances of models for scleroderma with special reference to tight skin mouse].
    Sasaki T
    Nihon Rinsho Meneki Gakkai Kaishi; 2001 Feb; 24(1):1-9. PubMed ID: 11280895
    [No Abstract]   [Full Text] [Related]  

  • 5. Transgenic analysis of scleroderma: understanding key pathogenic events in vivo.
    Denton CP; Abraham DJ
    Autoimmun Rev; 2004 Jun; 3(4):285-93. PubMed ID: 15246024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reactivity of collagen and elastic fibers under various experimental conditons].
    Riga IT; Ifrim M; Papilian V; Căpusau I; Bareliuc N; Maier N
    Verh Anat Ges; 1971; 66():553-8. PubMed ID: 4145055
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice.
    Blank M; Levy Y; Amital H; Shoenfeld Y; Pines M; Genina O
    Arthritis Rheum; 2002 Jun; 46(6):1689-90. PubMed ID: 12115202
    [No Abstract]   [Full Text] [Related]  

  • 8. Silicone does not potentiate development of the scleroderma-like syndrome in tight skin (TSK/+) mice.
    Frondoza C; Jones L; Rose NR; Hatakeyama A; Phelps R; Bona C
    J Autoimmun; 1996 Aug; 9(4):473-83. PubMed ID: 8864822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
    Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
    Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological characterization of (tight skin/NZB)F1 hybrid mice with connective tissue and autoimmune features resembling human systemic sclerosis.
    Bocchieri MH; Christner PJ; Henriksen PD; Jimenez SA
    J Autoimmun; 1993 Jun; 6(3):337-51. PubMed ID: 8397715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide synthase expression and activity in the tight-skin mouse model of fibrosis.
    Dooley A; Low SY; Holmes A; Kidane AG; Abraham DJ; Black CM; Bruckdorfer KR
    Rheumatology (Oxford); 2008 Mar; 47(3):272-80. PubMed ID: 18238792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of CpG-enriched plasmid administration on the tight-skin mouse model of scleroderma.
    Shen Y; Ichino M; Nakazawa M; Ikejima T; Kojima Y; Okuda K; Minami M
    J Autoimmun; 2005 May; 24(3):183-90. PubMed ID: 15848040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of skin fibrosis and autoantibodies by infusion of immunocompetent cells from tight skin mice into C57BL/6 Pa/Pa mice.
    Phelps RG; Daian C; Shibata S; Fleischmajer R; Bona CA
    J Autoimmun; 1993 Dec; 6(6):701-18. PubMed ID: 8155252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse.
    Ong VH; Evans LA; Shiwen X; Fisher IB; Rajkumar V; Abraham DJ; Black CM; Denton CP
    Arthritis Rheum; 2003 Jul; 48(7):1979-91. PubMed ID: 12847692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of fibrosis.
    Bocchieri MH; Jimenez SA
    Rheum Dis Clin North Am; 1990 Feb; 16(1):153-67. PubMed ID: 2406805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of IL-12 encoding plasmid administration on tight-skin mouse.
    Tsuji-Yamada J; Nakazawa M; Takahashi K; Iijima K; Hattori S; Okuda K; Minami M; Ikezawa Z; Sasaki T
    Biochem Biophys Res Commun; 2001 Jan; 280(3):707-12. PubMed ID: 11162578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tight skin (Tsk) mutation in the mouse, a model for human fibrotic diseases, is tightly linked to the beta 2-microglobulin (B2m) gene on chromosome 2.
    Siracusa LD; Christner P; McGrath R; Mowers SD; Nelson KK; Jimenez SA
    Genomics; 1993 Sep; 17(3):748-51. PubMed ID: 7902327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell accumulation and cytokine expression in the tight skin mouse model of scleroderma.
    Wang HW; Tedla N; Hunt JE; Wakefield D; McNeil HP
    Exp Dermatol; 2005 Apr; 14(4):295-302. PubMed ID: 15810888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mercuric chloride induces a strong immune activation, but does not accelerate the development of dermal fibrosis in tight skin 1 mice.
    Hansson M; Abedi-Valugerdi M
    Scand J Immunol; 2004 May; 59(5):469-77. PubMed ID: 15140057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
    J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.